EMPOWERING PHYSICIANS WITH EVIDENCE-BASED CONTENT
 

Home > Browse Topics

<< Emergency Department Management Of Priapism

Controversies And Cutting Edge

There is a lack of evidence substantiating novel therapies for the treatment of ischemic priapism. Most data are confined to case reports or limited studies. For example, intracavernosal methylene blue has been shown as a potential therapy for ischemic priapism in 2 studies,66,67 but, to our knowledge, no comparative studies between methylene blue and phenylephrine exist. In a case report, a 4 mg/kg intramuscular dose of ketamine was used to treat priapism caused by dexmethylphenidate in a pediatric patient.68

To continue reading, please log in or purchase access.

Related Links:

EMplify, the new Emergency Medicine Practice podcast, is now available

Evidence Based, LLSA Study Guides

 

About EB Medicine:

Products:

Accredited By:

ACCME ACCME
AMA AMA
ACEP ACEP
AAFP AAFP
AOA AOA
AAP AAP

Endorsed By:

AEMAA AEMAA
HONcode HONcode
STM STM

 

Last Modified: 05/24/2017
© EB Medicine